Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Rosie O'Donnell, an actress and comedian, recently posted about her weight loss process matter-of-factly. She is 62 years old ...

Eli Lilly launched its diabetes and weight-loss drug Mounjaro in India, ahead of Novo Nordisk, aiming at a market grappling ...

Endometriosis is a gynaecological condition where tissue similar to the lining of the uterus grows outside the uterus. It can ...

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

Amy Schumer had some positive praise for Mounjaro after a not-so-great experience with Wegovy years prior. "Three years ago, ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...

Mounjaro may also be used for other conditions as determined by your GP. It's possible that Mounjaro might help ease some ...